Approximately 14–25% of women of reproductive age experience irregular menstrual cycles, which may be associated […]
New Product Launch: Clomiphene Citrate Tablets, USP
Currently browsing: News
Camber Launches Raltegravir Tablets 400 mg
Camber Pharmaceuticals has launched Raltegravir Tablets 400 mg [ral-TEG-ra-veer], the only available generic for Isentress® […]
Specialty Generics: Where Access Meets Affordability
Executive Summary • Specialty generics can expand access and affordability by increasing competition and providing […]
Buprenorphine and Naloxone Sublingual Films Added to Portfolio
Camber Pharmaceuticals has launched buprenorphine and naloxone sublingual films [BUE-pre-NOR-feen and nal-OX-one suhb-ling-gwl], generic for […]
Buprenorphine and Naloxone Sublingual Tablets Added to Portfolio
Camber Pharmaceuticals has launched Buprenorphine and Naloxone Sublingual Tablets [BUE-pre-NOR-feen and nal-OX-one suhb-ling-gwl], generic for […]
New to Camber’s Portfolio: Losartan Potassium and Hydrochlorothiazide Tablets
Camber Pharmaceuticals has launched Losartan Potassium and Hydrochlorothiazide Tablets [loe-SAR-tan poe-TAS-ee-um and hye-droe-klor-oh-THYE-a-zide], generic for […]
NACDS TSE 2026 Event Recap
NACDS TSE 2026 in Boston was nothing short of amazing! From connecting with customers and […]
Camber Specialty Marks First Day 1 Injectable Launch
Camber Specialty, a division of Camber Pharmaceuticals, has launched Sugammadex Injection [soo-GAM-ma-dex], its first Day […]
New to Camber’s Portfolio: Olmesartan medoxomil, Amlodipine and Hydrochlorothiazide Tablets
According to the CDC, about 40-45% of adults in the U.S. have hypertension. Indicated for […]
Camber Pharmaceuticals Honored as Second Merit Finalist at 2026 DIANA Awards
Camber Pharmaceuticals is proud to have been named a Second Merit Finalist for the 2026 […]